Original Article
Copyright ©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2011; 17(8): 987-995
Published online Feb 28, 2011. doi: 10.3748/wjg.v17.i8.987
Figure 1
Figure 1 Intraperitoneal glucose tolerance test and insulin tolerance test in normal pellet diet-fed control rats and high fat diet-fed/streptozotocin induced type 2 diabetic rats. A: Serum glucose during intraperitoneal glucose tolerance test in normal pellet diet (NPD)-fed rats and high fat diet (HFD)-fed/streptozotocin (STZ) induced diabetic rats (n = 5/group); B: Percentage of initial glucose level during insulin tolerance test in NPD-fed rats and HFD-fed/STZ induced diabetic rats (n = 5/group). bP < 0.01 vs NPD group.
Figure 3
Figure 3 Free fatty acid and adipocytokines in diabetic rats after 8 wk treatment. A: Values of free fatty acid (FFA) in diabetes after 8 wk treatment; B: Values of tumor necrosis factor-α (TNF-α) in diabetes after 8 wk treatment; C: Values of interleukin-6 (IL-6) in diabetes after 8 wk treatment. CON: Control group; MOD: Type 2 diabetes model group; LDY: Low-dose Yi-Qi-Zeng-Min-Tang (YQZMT) group; MDY: Medium-dose YQZMT group; HDY: High-dose YQZMT group; ROS: Rosiglitazone group. Bar graphs indicate mean ± SE. bP < 0.01 vs CON group; dP < 0.01 vs MOD group.
Figure 2
Figure 2 Intraperitoneal glucose tolerance test and insulin tolerance test in diabetic rats after 8 wk of treatment. A: Serum glucose during intraperitoneal glucose tolerance test (IPGTT) in diabetic rats (n = 5/group); B: Percentage of initial glucose level during insulin tolerance test (ITT) in diabetic rats (n = 5/group). YQZMT: Yi-Qi-Zeng-Min-Tang; CON: Control group; MOD: Type 2 diabetes model group; LDY: Low-dose YQZMT group; MDY: Medium-dose YQZMT group; HDY: High-dose YQZMT group; ROS: Rosiglitazone group. aP < 0.05, bP < 0.01 vs CON group; cP < 0.05, dP < 0.01 vs MOD group.